Close Menu

As sequencing becomes ever cheaper, genome profiling will move from being used in the clinic in cases of rare diseases to more everyday health issues, says Amy Dockser Marcus in The Wall Street Journal. "Whole-genome sequencing will not stay confined to extremely rare cases of obscure diseases," says Robert Green from Brigham and Women's Hospital and Harvard Medical School.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.

Science reports that Science Foundation Ireland is seeking annual budget increases.

According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.

In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.